Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
TSHA | Taysha Gene Therapies, Inc. | Stalfort John A III | Director | Aug 16, 2023 | Buy | $0.90 | 388,889 | 350,000 | 999,381 | Aug 16, 2023, 08:53 PM | |
TSHA | Taysha Gene Therapies, Inc. | Stalfort John A III | Director | Aug 16, 2023 | Buy | $0.90 | 388,889 | 350,000 | 884,290 | Aug 16, 2023, 08:53 PM | |
ABOS | Acumen Pharmaceuticals, Inc. | Stalfort John A III | Director | Jul 06, 2021 | Buy | $16.00 | 35,000 | 560,000 | 172,324 | Jul 08, 2021, 06:17 PM | |
VRCA | Verrica Pharmaceuticals Inc. | Stalfort Sean | Director | Aug 13, 2020 | Buy | $6.45 | 15,550 | 100,297 | 446,410 | Aug 17, 2020, 04:39 PM | |
VRCA | Verrica Pharmaceuticals Inc. | Stalfort Sean | Director | Aug 14, 2020 | Buy | $6.38 | 15,700 | 100,166 | 462,110 | Aug 17, 2020, 04:39 PM | |
DOVA | Dova Pharmaceuticals Inc. | Stalfort Sean | Director | Nov 12, 2019 | Option Exercise | $27.50 | 635,665 | 17,480,788 | 0 | Nov 12, 2019, 04:40 PM | |
VRCA | Verrica Pharmaceuticals Inc. | Stalfort Sean | Director | Jan 07, 2019 | Buy | $10.45 | 9,221 | 96,386 | 430,860 | Jan 07, 2019, 08:54 PM | |
DOVA | Dova Pharmaceuticals Inc. | Stalfort Sean | Director | Dec 20, 2018 | Buy | $6.26 | 31,000 | 194,060 | 635,665 | Dec 21, 2018, 05:07 PM |